UK Markets close in 2 hrs 4 mins

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
58.62-0.08 (-0.14%)
At close: 04:00PM EST
57.77 -0.85 (-1.45%)
After hours: 04:23PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3100.00
52-week low 350.50
50-day moving average 366.33
200-day moving average 370.78

Share statistics

Avg vol (3-month) 3668.19k
Avg vol (10-day) 3908.48k
Shares outstanding 553.65M
Implied shares outstanding 6N/A
Float 848.51M
% held by insiders 114.49%
% held by institutions 191.26%
Shares short (13 Oct 2022) 45.63M
Short ratio (13 Oct 2022) 45.77
Short % of float (13 Oct 2022) 411.71%
Short % of shares outstanding (13 Oct 2022) 410.55%
Shares short (prior month 14 Sept 2022) 45.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin -4.47%
Operating margin (ttm)-1.40%

Management effectiveness

Return on assets (ttm)-0.80%
Return on equity (ttm)-4.72%

Income statement

Revenue (ttm)335.63M
Revenue per share (ttm)6.57
Quarterly revenue growth (yoy)46.20%
Gross profit (ttm)252.23M
EBITDA -685k
Net income avi to common (ttm)-15.01M
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)330.5M
Total cash per share (mrq)6.19
Total debt (mrq)28.66M
Total debt/equity (mrq)6.93
Current ratio (mrq)10.04
Book value per share (mrq)4.67

Cash flow statement

Operating cash flow (ttm)-2.74M
Levered free cash flow (ttm)1.57M